Familial gastric type 1 neuroendocrine tumor Advocacy Hub | UniteRare

Regulatory Watchboard

1 event

Sep 2020

Detectnet: FDA approved

indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Familial gastric type 1 neuroendocrine tumor.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Familial gastric type 1 neuroendocrine tumor.
Search all trials →

Search clinical trials for Familial gastric type 1 neuroendocrine tumor →

Recent News & Research

No recent news articles indexed yet for Familial gastric type 1 neuroendocrine tumor.
Search PubMed for Familial gastric type 1 neuroendocrine tumor →

Browse all Familial gastric type 1 neuroendocrine tumor news →

Specialist Network

No specialists currently listed for Familial gastric type 1 neuroendocrine tumor.

View all Familial gastric type 1 neuroendocrine tumor specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰